In urachal adenocarcinomas, AMACR was found to be positive in a low number of cases (17%), while in colorectal and primary bladder adenocarcinomas, a significantly higher number (>66%) of cases exhibited AMACR-reactivity [17, 77, 343, 344]. The gene discussed is AMACR; the disease is bladder urachal adenocarcinoma.